A patient-derived organoid-based study identified an ASO targeting SNORD14E for endometrial cancer through reducing aberrant FOXM1 Expression and β-catenin nuclear accumulation

BACKGROUND: Most of the endometrial cancer (EC) patients are diagnosis in early stage with a good prognosis while the patients with locally advanced recurrent or metastatic result in a poor prognosis. Adjuvant therapy could benefit the prognosis of patients with high-risk factors. Unfortunately, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xi, Liu, Xin, Li, Qian-hui, Lu, Bing-feng, Xie, Bu-min, Ji, Yu-meng, Zhao, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478245/
https://www.ncbi.nlm.nih.gov/pubmed/37667311
http://dx.doi.org/10.1186/s13046-023-02801-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478245/
https://www.ncbi.nlm.nih.gov/pubmed/37667311
http://dx.doi.org/10.1186/s13046-023-02801-2

Ejemplares similares